Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00171366 · ClinicalTrials.gov registry record · Phase 3
A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril.
A Phase 3 study, sponsored by Novartis.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,422
- Enrollment target
NCT00171366: Completed Phase 3 study, sponsored by Novartis.
NCT00171366 is a Phase 3 study that has completed, run by Novartis. The registered enrollment target is 1,422 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (84% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00171366, a Phase 3 study, has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,422 participants
- Enrollment target
Study Summary
Comparison of the safety and efficacy of the combination of amlodipine/Benazepril to amlodipine monotherapy in patients with non-essential hypertension, not controlled on amlodipine alone.
Interventions
- DRUG amlodipine/benazepril
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,422 participants |
| Start Date | 2004-07 |
| Est. Completion | 2005-07 |
| Phase | Phase 3 |
What the finished NCT00171366 record still lists
NCT00171366 is an interventional study that assigns participants to a tested intervention. Its 1,422 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (84% higher).
The record links to 0 conditions, and to 1 intervention - of which amlodipine/benazepril is the first listed.
NCT00171366 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00171366 about?
NCT00171366 is a clinical study titled "A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril.". Comparison of the safety and efficacy of the combination of amlodipine/Benazepril to amlodipine monotherapy in patients with non-essential hypertension, not controlled on amlodipine alone.
What is the current status of trial NCT00171366?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,422 participants. The study started on 2004-07. Estimated completion is 2005-07.
What interventions are being tested in trial NCT00171366?
The interventions under investigation include: amlodipine/benazepril (DRUG).
Who is sponsoring clinical trial NCT00171366?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00171366's enrollment target sits among peer trials
1,422 169th of 2000 higher than 1,832 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05890404 · 1,410 participants · NA
SGM Evidenced-Based Mental Healthcare Implementation
- NCT07042451 · 1,410 participants · NA
An Evaluation of the Pink Cloud Application in Post- Treatment Substance Use Disorder Support
- NCT07222566 · 1,410 participants · Phase 3
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- NCT05992935 · 1,405 participants · Phase 1
Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia